Table 2.
Characteristics of the participants (N=686).
| Outcome | Women | Men | |||
| Participants, n (%) | 406 (59.2) | 280 (40.8) | |||
| Age (years), median (IQR) | 71 (68-75) | 72 (68-76) | |||
| Height (m), mean (SD) | 1.55 (0.06) | 1.68 (0.06) | |||
| Weight (kg), median (IQR) | 66.0 (59.6-73.2) | 79.3 (71.6-88.5) | |||
| BMI (kg/m2), median (IQR) | 27.4 (24.4-30.1) | 28.1 (25.8-31.2) | |||
| ASMa (kg), median (IQR) | 14.4 (13.1-15.7) | 20.2 (18.7-22.3) | |||
| SMIb (kg/m2), median (IQR) | 5.9 (5.5-6.4) | 7.2 (6.7-7.7) | |||
| Calf circumference (m)c, median (IQR) | 0.36 (0.34-0.38) | 0.37 (0.35-0.39) | |||
|
|
P25 | 0.34 | 0.35 | ||
|
|
P50 | 0.36 | 0.37 | ||
|
|
P75 | 0.38 | 0.39 | ||
| Femur length (m), median (IQR) | 0.36 (0.34-0.38) | 0.39 (0.36-0.4) | |||
| Handgrip strength (kg), mean (SD) | 22.6 (4.3) | 37.5 (6.8) | |||
| 5STSd (s), median (IQR) | 12.1 (10.6-14.1) | 12.2 (10.7-14.2) | |||
| Vertical power (W/kg)c, mean (SD) | 5.0 (1.1) | 5.89 (1.0) | |||
|
|
P25 | 4.5 | 5.4 | ||
|
|
P50 | 5.1 | 6.0 | ||
|
|
P75 | 5.7 | 6.6 | ||
| Physical activity levels, n (%) |
|
|
|||
|
|
Sedentary | 22 (5.4) | 42 (15.0) | ||
|
|
Physically active | 392 (93.8) | 239 (85.1) | ||
| Sarcopenia prevalence, n (%) |
|
|
|||
|
|
SARCHGe+ASM | 20 (4.9) | 11 (3.9) | ||
|
|
SARCHG+SMI | 7 (1.7) | 7 (2.5) | ||
|
|
SARC5STS+ASM | 46 (11.3) | 30 (10.7) | ||
|
|
SARC5STS+SMI | 18 (4.4) | 24 (8.6) | ||
| Frailty phenotype, n (%) | 11 (2.7) | 10 (3.6) | |||
aASM: appendicular skeletal mass.
bSMI: skeletal muscle index.
cPercentiles are shown as P25, P50, and P75.
d5STS: 5 times sit-to-stand.
eHG: handgrip strength.